✦ LIBER ✦

Lack of Efficacy of 24-h Infusional Topotecan in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Trial

✍ Scribed by Maurie Markman; John A. Blessing; Koen DeGeest; Mark Morgan; Katherine Y. Look; Thomas J. Herzog; Peter G. Rose

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altretamine (Hexamethylmelamine) in Plat

✍ Maurie Markman; John A. Blessing; David Moore; Harrison Ball; Samuel S. Lentz 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase II Evaluation of 24-h Continuous I

✍ Maurie Markman; John A. Blessing; Ronald D. Alvarez; Parviz Hanjani; Steven Wagg 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase II Trial of CI-958 in Recurrent Pl

✍ Mark A. Hoffman; John A. Blessing; Mark Morgan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Phase I Trial of Ifosfamide and 24-h Inf

✍ Maurie Markman; David Spriggs; Robert A. Burger; Linda F. Carson; Samuel S. Lent 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Phase II Trial of Pyrazoloacridine in Re

✍ Steven C. Plaxe; John A. Blessing; Michael A. Bookman; William T. Creasman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A phase I trial of gemcitabine and topot

✍ M. Dwight Chen; Gini F. Fleming; Suann Mitchell; Ira Horowitz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB